A. van Dalen - Concepedia

Author

A. van Dalen

Groene Hart Ziekenhuis

Also Known As

A Dalen, A Van Dalen, A van Dalen, A. Dalen, A. VAN DALEN, A. Van Dalen, A. van Dalen, Astrid van Dalen, van Dalen, A

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Groene Hart Ziekenhuis Ludwig-Maximilians-Universität München Hospital Clínic de Barcelona University of Groningen ALS Centrum Nederland

About

A. van Dalen is an author at Groene Hart Ziekenhuis specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	587
2	Engineering	5	5	103
3	Health Sciences	2	2	70
4	Natural Sciences	1	1	16
5	Nursing	1	1	21

A. van Dalen

Publications

878

Citations

H-Index

Page 1

	Year	Citations
Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde Durk Fekkes, A. van Dalen, Margriet Edelman, Journal of Chromatography B Biomedical Sciences and Applications Amino AcidsBiochemistryGas ChromatographyMedicineBioanalysis	1995	159
Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 Workshop Torgny Stigbrand, Cai S, Laurent Bellanger, Tumor Biology	1998	78
Prognostic Significance of CA 125 and TPS Levels after 3 Chemotherapy Courses in Ovarian Cancer Patients A. van Dalen, Judith Favier, Alexander Burges, Gynecologic Oncology Ca 125MedicineGynecologyPathologyTps Levels	2000	56
Gallstone Size and the Risk of Gallbladder Cancer C. J. Moerman, Frank J. Lagerwaard, H. Bas Bueno de Mesquita, Scandinavian Journal of Gastroenterology Surgical OncologyEus-guided Gallbladder DrainageBiliary TractMedicineBiliary Cancer	1993	50
Treatment response in metastatic breast cancer. A multicentre study comparing UICC criteria and tumour marker changes A. van Dalen, K J Heering, Vivian Barak, The Breast Uicc CriteriaBreast OncologyCancer PathologyCancer ManagementPathology	1996	43
Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. A Harłozińska, P Sedlaczek, J Kulpa, PubMed Vegf ValuesTumor EffusionsAngiogenesisTumoral PathologyMedicine	2004	42
TPS in Breast Cancer &ndash; A Comparative Study with Carcinoembryonic Antigen and CA 15-3 A. van Dalen Tumor Biology	1992	41
Nine years of practical experience with phenylamide resistance in Phytophthora infestans in the Netherlands L.C. Davidse, J. Henken, A. van Dalen, European Journal of Plant Pathology BiologyEngineeringPesticide ResistanceEntomologyPlant Protection	1989	38
Papillomatosis of the Esophagus Arne K. Sandvik, Steinar Aase, K. H. Kveberg, Journal of Clinical Gastroenterology	1996	36
The Prognostic Significance of Increasing Marker Levels in Metastatic Breast Cancer Patients with Clinically Complete Remission, Partial Remission or Stable Disease A. van Dalen, Vivian Barak, Andrea Cremaschi, The International Journal of Biological Markers Prognostic EvaluationPrognostic BiomarkersBreast OncologyLead TimeHealth Sciences	1998	27

Page 1